about
Limited impact of Cntn4 mutation on autism-related traits in developing and adult C57BL/6J mice.Characterization and reversal of Doxorubicin-mediated biphasic activation of ERK and persistent excitability in sensory neurons of Aplysia californica.Doxorubicin and cyclophosphamide induce cognitive dysfunction and activate the ERK and AKT signaling pathwaysSex-specific effects of cytotoxic chemotherapy agents cyclophosphamide and mitomycin C on gene expression, oxidative DNA damage, and epigenetic alterations in the prefrontal cortex and hippocampus - an aging connectionPerinatal Exposure to Glufosinate Ammonium Herbicide Impairs Neurogenesis and Neuroblast Migration through Cytoskeleton DestabilizationConstitutive loss and acute pharmacological manipulation of ErbB4 signaling do not affect attention and inhibitory control in mice.Chemo brain: From discerning mechanisms to lifting the brain fog-An aging connection.Minocycline, a putative neuroprotectant, co-administered with doxorubicin-cyclophosphamide chemotherapy in a xenograft model of triple-negative breast cancer.Changes in brain white matter integrity after systemic treatment for breast cancer: a prospective longitudinal study.Decline in Cognitive Function in Older Adults With Early-Stage Breast Cancer After Adjuvant Treatment.Growth of malignant extracranial tumors alters microRNAome in the prefrontal cortex of TumorGraft mice.Effects of Cyclophosphamide (CYP) and/or Doxorubicin (DOX) in a Murine Model of Post-Chemotherapy Cognitive Impairment.In vivo neuroimaging and behavioral correlates in a rat model of chemotherapy-induced cognitive dysfunction.Repeated five-day administration of L-BMAA, microcystin-LR, or as mixture, in adult C57BL/6 mice - lack of adverse cognitive effects.Neuroimmunology of Behavioral Comorbidities Associated With Cancer and Cancer Treatments.Effects of neoadjuvant chemotherapy on minimum alveolar concentration values of sevoflurane and desflurane in patients with hepatocellular carcinoma complicated with jaundice.
P2860
Q30388673-4F3D7A80-891B-41FC-A166-D277E44AAE8FQ33866915-BAA109E5-C599-430E-A44F-4E603C587948Q36021403-6BDE4B5A-F0FD-4835-9A9A-83386858D1A2Q37049097-0E248477-8386-4330-82E0-6E2438204128Q37159258-674BB7C2-615E-450B-806B-3CD585DBB96FQ38632355-35D443D9-7621-480C-9554-A5790C0AB395Q38665685-51467C03-2677-4835-85D7-DBF852A2D7ECQ38750471-ECE1B698-7DDF-4710-B6DB-F2664CA2FF64Q38909932-2C455680-A89E-43D8-A045-69935ECDF894Q39544939-410217AB-4C6D-472C-9839-0E7A29845FFBQ44833373-A9B1EE5B-F50A-4D1B-B27E-D0DE3D81AC4BQ47566624-21E7BC0D-46B0-4F8E-B6F5-1AE0D27F000BQ47883693-37F5F24C-E97E-4B29-9481-874A0688F809Q48112588-358E76F6-3281-49E3-ACF8-15D8AE7A5382Q55341418-8B4481BD-AE2A-451C-B057-1B7D46B176F0Q55346743-72E81CD6-8805-4839-B864-EF7AB02AA782
P2860
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Cognitive impact of cytotoxic agents in mice.
@en
Cognitive impact of cytotoxic agents in mice.
@nl
type
label
Cognitive impact of cytotoxic agents in mice.
@en
Cognitive impact of cytotoxic agents in mice.
@nl
prefLabel
Cognitive impact of cytotoxic agents in mice.
@en
Cognitive impact of cytotoxic agents in mice.
@nl
P2093
P2860
P1433
P1476
Cognitive impact of cytotoxic agents in mice.
@en
P2093
P2860
P2888
P356
10.1007/S00213-014-3636-9
P577
2014-06-04T00:00:00Z
P6179
1050371053